Business Model

The Company operating business emerges from a ten-year medical imaging research. Due to the evolutionary dynamics of its application field, it is consequently connected to scientific and technological research.
The Company market strategy is to establish technological and commercial partnerships with OEM, PACS and GUI Producers, Review Station Producers, In-vitro Diagnostics devices (microscopes, automatic devices for the preparation of slides fo Indirect ImmunoFluorescence) manufacturers. Furthermore, through distributors, the company is targeting also end-user customers (hospitals, diagnostics laboratories, etc.).